According to a new report from Intel Market Research, the global sertraline market was valued at US$ 7.4 billion in 2024 and is projected to reach US$ 9.8 billion by 2032, growing at a CAGR of 3.7% during the forecast period (2024–2032). This sustained growth is primarily driven by the escalating global prevalence of mental health disorders, increasing awareness about antidepressant...